SOCS3 protein expression predicts the responses of advanced non-small cell lung cancer patients to platinum-based chemotherapy

BACKGROUND: This study sought to assess the relationship between suppressor of cytokine signaling 3 (SOCS3) expression, SOCS3 promoter methylation status, and platinum-based chemotherapy responses in advanced non-small cell lung cancer (NSCLC) patients. METHODS: A total of 400 advanced NSCLC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Ming, Liu, Tian-Yang, Li, Shi-Qi, Han, Xin-Ai, Song, Rui, Wang, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929795/
https://www.ncbi.nlm.nih.gov/pubmed/36819530
http://dx.doi.org/10.21037/atm-22-6065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929795/
https://www.ncbi.nlm.nih.gov/pubmed/36819530
http://dx.doi.org/10.21037/atm-22-6065

Ejemplares similares